Design and development of polymer conjugates as anti-angiogenic agents
- 1 November 2009
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 61 (13) , 1159-1176
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A″-DTPA) conjugates show increased kidney accumulationJournal of Controlled Release, 2008
- An orally delivered small-molecule formulation with antiangiogenic and anticancer activityNature Biotechnology, 2008
- Nanoconjugate based on polymalic acid for tumor targetingChemico-Biological Interactions, 2008
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesisAngiogenesis, 2006
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004
- Metronomic scheduling: the future of chemotherapy?The Lancet Oncology, 2001
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971